Edgewise Therapeutics Inc (EWTX) USD0.0001

Sell:$17.35Buy:$17.37$0.01 (0.06%)

NASDAQ:0.95%
Market closed | Prices delayed by at least 15 minutes
Sell:$17.35
Buy:$17.37
Change:$0.01 (0.06%)
Market closed | Prices delayed by at least 15 minutes
Sell:$17.35
Buy:$17.37
Change:$0.01 (0.06%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
2 May 2024
Robert Michael CarruthersCFO
Sell
Tax related
2,157$18.91$40,788.8735,230
2 May 2024
Joanne M DonovanChief Marketing Officer
Sell
Tax related
3,682$18.91$69,626.6219,897
2 May 2024
Kevin KochPresident/CEO
Sell
Tax related
3,152$18.91$59,604.3214,478
2 May 2024
Behrad Mokhtar-DerakhshanChief Level Officer
Sell
Tax related
1,718$18.91$32,487.3813,422
2 May 2024
Alan J RussellPresident
Sell
Tax related
1,576$18.91$29,802.167,238
2 May 2024
John R MooreGeneral Counsel
Sell
Tax related
1,956$18.91$36,987.963,252
9 February 2024
Behrad Mokhtar-DerakhshanChief Level Officer
Sell
Option/Award related
4,800$20.04$96,209.287,020
9 February 2024
John R MooreGeneral Counsel
Sell
Option/Award related
8,029$20.01$160,657.080
8 February 2024
Behrad Mokhtar-DerakhshanChief Level Officer
Sell
Option/Award related
4,600$20.01$92,048.767,020
8 February 2024
John R MooreGeneral Counsel
Sell
Option/Award related
3,813$20.01$76,284.780

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 January 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
454,545$11.00$4,999,995.0014,436,497
26 December 2023
Alan J RussellPresident
Sell
Regular sell transaction (market)
172,585$9.33$1,610,097.243,606
23 January 2024
Robert Michael CarruthersCFO
Sell
Option/Award related
90,000$15.78$1,419,759.0029,024
7 February 2024
John R MooreGeneral Counsel
Sell
Option/Award related
17,993$20.00$359,863.600
9 February 2024
John R MooreGeneral Counsel
Sell
Option/Award related
8,029$20.01$160,657.080

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.